Login / Signup

Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50.

Nick FreemantleYingxin XuFlorence R WilsonPatricia GuyotChieh-I ChenSam KeepingGerasimos KonidarisKeith ChanAndreas KuznikKokuvi AtsouEmily GlowienkaJean-Francois PouliotGiuseppe GulloPetra Rietschel
Published in: Therapeutic advances in medical oncology (2022)
pembrolizumab.
Keyphrases
  • advanced non small cell lung cancer
  • systematic review
  • epidermal growth factor receptor
  • meta analyses
  • palliative care
  • combination therapy
  • open label
  • case control
  • clinical trial
  • study protocol